Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing the single result
Showing the single result
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Editor’s Note: Welcoming Remarks
1 × $0.00 Corrections to "Patton-Nelson Personal Consumption Tables 2018-19"
1 × $25.00 The valuation of the loss of future pension income
1 × $25.00 The demise of hedonic damages claims in tort litigation
1 × $25.00 Subtotal: $75.00